This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
MedX Health Corp. and Health Partners Group Limited Announce Successful Results of its Pilot Project in the United Kingdom and Move Towards A Partnership Agreement CI
MedX Health Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
MedX Health Corp announced that it has received CAD 1.02 million in funding CI
MedX Health Corp. Announcing Proposed Extension of Non-Brokered Private Placement Offering MT
MedX Health Corp announced that it expects to receive CAD 1.5 million in funding CI
MedX Health Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
MedX Health Corp Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
MedX Health Corp. Brief: Appointing Stephen Lockyer as CEO MT
MedX Health Corp Announces Resignation of Naman Damaghlatrous as Director CI
MedX Health Corp. Announces Chief Executive Officer Changes CI
MedX Health Corp Reports Earnings Results for the Full Year Ended December 31, 2022 CI
MedX Health Corp Auditor Raises 'Going Concern' Doubt CI
MedX Health Details Board Changes MT
MedX Health Corp Announces Board Changes CI
MedX Health, PharmaChoice Enter MOU to Launch MedX Teledermatology Screening Platform Across Canada MT
MedX Health Corp and Pharmachoice Announces Agreement to Launch Medx Teledermatology Screening Platform Across Canada CI
MedX Health Corp announced that it has received CAD 1.465 million in funding from Forest Lane Holdings Limited CI
MedX Health Plans to Undertake $1.5 Million Convertible Debenture Financing MT
MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited CI
MedX Health Corp announced that it has received CAD 1.5 million in funding from Forest Lane Holdings Limited CI
MedX Health Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
MedX Health Corp announced that it expects to receive CAD 1.5 million in funding from Forest Lane Holdings Limited CI
MedX Health Corp announced that it has received CAD 1.1 million in funding CI
MedX Health Corp announced that it has received CAD 1.1 million in funding from Forest Lane Holdings Limited and other investors CI
MedX Health Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Chart MedX Health Corp
More charts
MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.
More about the company
  1. Stock Market
  2. Equities
  3. MDX Stock
  4. News MedX Health Corp
  5. MedX Health Corp. Announcing Proposed Extension of Non-Brokered Private Placement Offering